AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇬🇭
RITUXIMAB in Ghana
6 products registered with FDA Ghana — 6 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| MABTHERA (RITUXIMAB) 100MG/10ML CONCENTRATE OR SOLUTION FOR INJECTION | UNKNOWN-c4b7b92d | — | active | 1 Oct 2030 |
| MABTHERA (RITUXIMAB) 100MG/10ML CONCENTRATE OR SOLUTION FOR INJECTION | UNKNOWN-1755670d | — | active | 1 Oct 2030 |
| RILAST 500MG/50ML CONCENTRATE FOR SOLUTION FOR INFUSION (RITUXIMAB) | UNKNOWN-ff070d36 | — | active | 1 Jul 2027 |
| RILAST 100MG/10ML CONCENTRATE FOR SOLUTION FOR INFUSION (RITUXIMAB) | UNKNOWN-3d4898c3 | — | active | 1 Jul 2027 |
| MABTHERA | UNKNOWN-fa5103ce | — | active | 1 Mar 2027 |
| MABTHERA | UNKNOWN-9a4bf97e | — | active | 1 Mar 2027 |
RITUXIMAB — FDA Ghana Registration Details
FDA Ghana (Ghana) has 6 registered products containing RITUXIMAB, of which 6 are currently active. Data is sourced directly from the official FDA Ghana drug register and refreshed daily.
Track RITUXIMAB registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.